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In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar
Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive
Diagnosis
Veerapandian Raja,a Santhanam Shanmughapriya,a* Murugesan Kanagavel,a Sergey C. Artiushin,b Sridhar Velineni,b
John F. Timoney,b Kalimuthusamy Natarajaseenivasana
Medical Microbiology Laboratory, Department of Microbiology, Centre of Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Indiaa; Gluck Equine
Research Center, University of Kentucky, Lexington, Kentucky, USAb
Leptospirosis is a serious zoonosis that is underdiagnosed because of limited access to laboratory facilities in Southeast
Asia, Central and South America, and Oceania. Timely diagnosis of locally distributed serovars of high virulence is crucial
for successful care and outbreak management. Using pooled patient sera, an expression gene library of a virulent Lepto-
spira interrogans serovar Autumnalis strain N2 isolated in South India was screened. The identified genes were character-
ized, and the purified recombinant proteins were used as antigens in IgM enzyme-linked immunosorbent assay (ELISA)
either singly or in combination. Sera (n 118) from cases of acute leptospirosis along with sera (n 58) from healthy sub-
jects were tested for reactivity with the identified proteins in an ELISA designed to detect specific IgM responses. We have
identified nine immunoreactive proteins, ArgC, RecA, GlpF, FliD, TrmD, RplS, RnhB, Lp28.6, and Lrr44.9, which were
found to be highly conserved among pathogenic leptospires. Apparently, the proteins ArgC, RecA, GlpF, FliD, TrmD, and
Lrr44.9 are expressed during natural infection of the host and undetectable in in vitro cultures. Among all the recombi-
nant proteins used as antigens in IgM ELISA, ArgC had the highest sensitivity and specificity, 89.8% and 95.5%, respec-
tively, for the conclusive diagnosis of leptospirosis. The use of ArgC and RecA in combination for IgM ELISA increased the
sensitivity and specificity to 95.7% and 94.9%, respectively. ArgC and RecA thus elicited specific IgM responses and were
therefore effective in laboratory confirmation of Leptospira infection.
Leptospirosis is a reemerging infectious disease of global impor-tance, caused by pathogenic spirochetes of the genus Lepto-
spira. Increased economic and recreational activity in pristine ar-
eas as well as flooding associated with climatic change has
increased human exposure to leptospires. Indeed, several large
outbreaks have been reported in Nicaragua (1, 2), Brazil (3), New
Caledonia (4), the Federated States of Micronesia (5), Japan (6),
and India (7–10) in recent years. Conventionally, culture positiv-
ity, seroconversion, or 4-fold rises in microscopic agglutination
test (MAT) titers are demonstrated for confirmation of leptospi-
rosis. Per WHO recommendations, the standard reference
method for diagnosis of leptospirosis isMAT (11). Enzyme-linked
immunosorbent assay (ELISA) offers reasonable sensitivity and
the possibility of handlingmany samples at a time. ELISAhas been
developed with a number of modifications (12).
Immune responses include antibodies to numerous leptospiral
proteins constitutively expressed or upregulated during infection
(13). Antibodies of the IgM isotype appear about 4 days after onset
of fever and headache and are responsible for clearance of lepto-
spires from the bloodstream. Hypothetically, proteins specifically
induced during in vivo growth but not expressed by in vitro cul-
tures have enhanced value because of their potential involvement
in pathogenesis and participation in acquired immune protective
responses (14). Examples of such proteins that have gained prom-
inence as diagnostic reagents and vaccine candidates are LigA and
LigB immunoglobulin-like proteins andHbpA expressed strongly
in vivo and found only on freshly isolated pathogenic Leptospira
species (15–18). The diagnostic and vaccine efficacy of LigA pro-
tein and its immunogenic epitopes has been studied extensively
(15, 19–23). Thus, studies of proteins increased in abundance in
vivo not only contribute to understanding of host-pathogen inter-
actions but also are helpful in design of novel diagnostics and
vaccines.
In the present study, we have identified in vivo-expressed pro-
teins of virulent Leptospira interrogans serovar Autumnalis strain
N2 through an expression gene library screening. The library was
screened with pooled patient sera, and IgM ELISA incorporating
the identified proteins was highly sensitive and specific for the
conclusive diagnosis of human leptospirosis.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Leptospira interrogans serovar
Autumnalis strainN2was used for the genomicDNA isolation and library
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construction. TheMATwas performed to evaluate serological evidence of
leptospiral infection (11). A panel of 12 reference strains was used which
included the following serogroups: Australis (serovarAustralis, strain Bal-
lico), Autumnalis (serovar Autumnalis, strain Akiyami A), Ballum (sero-
var Ballum, strain Mus 127), Bataviae (serovar Bataviae, strain Swart),
Canicola (serovar Canicola, strain Hond Utrecht IV), Icterohaemor-
rhagiae (serovar Icterohaemorrhagiae, strain RGA), Grippotyphosa
(serovar Grippotyphosa, strain Moskva V), Hebdomadis (serovar
Hebdomadis, strain Hebdomadis), Javanica (serovar Poi, strain Poi),
Pomona (serovar Pomona, strain Pomona), Sejroe (serovar Hardjo,
strain Hardjoprajitno), and Pyrogenes (serovar Pyrogenes, strain Sa-
linem). The strains were obtained from theWHOReference Centre for
Leptospirosis, Indian Council of Medical Research (ICMR), Regional
Medical Research Centre (RMRC), Port Blair, India, and maintained
by regular subculturing in Ellinghausen-McCullough-Johnson-Harris
(EMJH) bovine serum albumin-Tween 80 medium (Difco Laborato-
ries, USA) at the Medical Microbiology Laboratory, Bharathidasan
University, Tiruchirappalli, India.
Escherichia coli SOLR and XL1-Blue MRF= (Stratagene, La Jolla, CA)
were hosts for phage manipulation and plasmid excision. E. coli NovaBlue,
BL21(DE3), and BL21(DE3)pLysS (Novagen, Madison, WI) were used
for cloning and expression of recombinant proteins and were routinely
grown in Luria-Bertani (LB) broth or on LB agar.
Study site, patients, case definition, and ethics. The samples for this
study were obtained through our routine hospital-based surveillance at
Annal Mahatma Gandhi Memorial General Hospital, Tiruchirappalli,
Tamilnadu, India. Tiruchirappalli is a municipal corporation of urban
agglomeration surrounded by villages actively involved in agriculture (es-
pecially cultivation of rice, sugarcane, and groundnut) and cattle rearing.
In Tiruchirappalli, the temperature ranges from 28°C to 38°C, and the
geographical position of this area is 10.81°N latitude and 78.69°E longi-
tude.
In total, 118 serum samples (see Table S1 in the supplemental mate-
rial) with a MAT titer of1:160 were selected from a bank of 754 labora-
tory-confirmed samples (a positive IgM ELISA, isolation of leptospires
from the blood, seroconversion, or 4-fold rise in titer by MAT) collected
during the early phase of illness (0 to 10 days after the onset of disease).
The age and sex distributions of the confirmed cases included in the study
are given in Table S2 in the supplemental material. A total of 58 seroneg-
ative healthy controls selected from a group of cases matched with respect
to age (5 years) and sex and 98 patients who were hospitalized with a
clinical suspicion of leptospirosis and subsequently diagnosed as having
other illness based on laboratory evidence (MAT and ELISA negative for
leptospirosis) were also included to study the efficiency of the ELISA de-
veloped in the present study. Informedwritten consentwas obtained from
both cases and controls before sampling, and the study protocol was ap-
proved by the Institutional Ethics Committee (IEC) of Bharathidasan
University (DM/2007/101/373/Project No.2) as well as permitted by the
Directorate of Health Services (reference no. 5796/TV 1/07), Tamilnadu.
The obtained sera were stored at80°C until use.
Preparation of heat-extracted antigen. Leptospiral heat-extracted
antigen was prepared from 7-day-old leptospiral culture (1 108 to 2
108/ml) of L. interrogans serovar Autumnalis. The culture was killed by
formalin (final concentration, 0.5% [vol/vol]), heated in a boiling wa-
ter bath for 30 min, and centrifuged for 30 min at 10,000  g. The
supernatant was used as heat-extracted antigen. Protein concentra-
tions were determined by the bicinchoninic acid (BCA) method
(Sigma, St. Louis, MO).
Polyclonal antisera. Polyclonal antisera were raised in New Zealand
White rabbits by subcutaneous administration of 1 l of N-acetylmu-
ramyl-L-alanyl-D-isoglutamine (Sigma, St. Louis, MO) and 100 g of
heat-extracted antigen prepared from laboratory-grown L. interrogans se-
rovar Autumnalis strainN2 or purified recombinant proteins adsorbed to
aluminum hydroxide (Alhydrogel; Accurate Chemical & Scientific Corp.,
Westbury, NY). Booster injections containing 100 g (subcutaneous) of
the antigen were administered 14 and 28 days after the primary immuni-
zation. Serumwas obtained 35 days after the primary immunization (23).
The study protocolwas approved by the Institutional Animal Ethics Com-
mittee (IAEC) of Bharathidasan University (BDU/IAEC/2011/29/29-03-
2011).
GenomicDNA library construction and screening.A ZAPII library
containing 3- to 5-kb random fragments of L. interrogans serovar Autum-
nalis strain N2 was screened to identify phage that expressed gene prod-
ucts reactive with pooled patient sera (see Table S3 in the supplemental
material) as described elsewhere (24) with some modifications. The sec-
ondary antibody was horseradish peroxidase (HRP)-labeled antihuman
IgG (Sigma, St. Louis, MO) diluted 1:4,000. Secondary screening was per-
formed with hyperimmune serum (HIS) raised in rabbit against heat-
extracted antigen to identify plaques reactive with patient sera but not
HIS.Negative clones that did not reactwithHISwere considered potential
producers of in vivo antigens.
DNA sequencing and expression of recombinant proteins. Sus-
pected plaques on agar plugs were transferred to 500 l of SM buffer and
allowed to elute overnight. Plasmids containing the inserts were rescued
from selective reactive phages by using ExAssist helper phage and E. coli
SOLR according to the manufacturer’s instructions. Plasmid DNA was
isolated from reactive clones using a QIAprep spin miniprep kit (Qiagen,
Valencia, CA) and sequenced in a commercial sequencing facility (Mac-
rogen, South Korea) using T3, T7, and custom-designed primers. Se-
quenceswere editedwithChromas 1.61 (TechnelysiumPty. Ltd., Queens-
land, Australia) and aligned and connected with DNASIS (Hitachi
Software Engineering Co., Ltd., San Francisco, CA). DNA sequences thus
obtained were compared with the whole-genome sequences of L. interro-
gans serovar Lai strain 56601 and L. interrogans serovar Copenhageni
strain Fiocruz L1-130, and homologies were identified by a BLAST search
(http://www.ncbi.nlm.nih.gov/BLAST/).
Primer sequences used for the specific amplification of the identified
genes are given in Table S4 in the supplemental material. Following PCR
amplification (see Fig. S1A in the supplemental material), the amplicons
were cloned into predigested pET15b (Novagen, Madison, WI) (argC,
glfP, fliD, trmD, rplS, rnhB, lp28.6, and lrr44.9) or pRSETA (Invitrogen,
USA) (recA). Recombinant plasmids were transformed into E. coli
BL21(DE3) for pET15b and E. coli BL21(DE3)pLysS for pRSETA. The
presence of the correct inserts was confirmed by colony PCR, restriction
endonuclease analysis (REA), and DNA sequencing (see Fig. S1B in the
supplemental material).
Expression of His6 proteins was induced with 1 mM isopropyl--D-
thiogalactopyranoside (IPTG)when cultures reached an optical density at
600 nm (OD600) of 0.6, and cells were harvested after 2 to 3 h. Recombi-
nant His-tagged proteins were isolated using Talon metal affinity resin
(Clontech Laboratories, Inc.) in buffer containing 8 M urea according to
the manufacturer’s recommendations. The purified recombinant pro-
teins were dialyzed against 10mMTris (pH 7.5) containing 50mMNaCl,
and their immunoreactivity was assessed by immunoblotting.
SDS-polyacrylamide gel electrophoresis and immunoblotting. Pro-
teins were separated on 10% acrylamide gels by SDS-PAGE and trans-
ferred electrophoretically to a nitrocellulose membrane. After blocking,
membranes were incubated with pooled patient sera or rabbit HIS fol-
lowed by incubation with anti-human or anti-rabbit IgG conjugated with
horseradish peroxidase (Sigma, St. Louis, MO). Membranes were devel-
oped and visualized using 4-chloro-1-naphthol (Sigma, St. Louis, MO).
Enzyme-linked immunosorbent assay. A checkerboard titration was
performed in 96-well flat-bottom polystyrene Microtest III assay plates
(Falcon; Becton, Dickinson, Oxnard, CA) with patient and control sera in
doubling dilutions and tested against 0.1 to 5.0 g/well of antigen to
determine the optimum concentration of the recombinant proteins in
diagnosis. Wells were coated with 0.2 g of recombinant proteins (opti-
mized concentration in single) using carbonate buffer (pH 9.6) overnight
at 4°C followed by blocking with 4% nonfat dry milk. All sera were added
in a dilution of 1:200 in triplicate and incubated for 1 h at 37°C. Bound
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IgMwas detected using peroxidase-conjugated anti-human IgM (Sigma),
followed by development using 0.08% (wt/vol) 5-aminosalicylic acid.Op-
tical densities (ODs)were read at 490 nm. For combination ELISA, check-
erboard titration was carried out to determine the best working concen-
tration of the recombinant proteins in combination. Combinations were
made by mixing ArgC (0.2 g) and RecA (0.1 g) (combo 1); GlpF (0.1
g) and FliD (0.2 g) (combo 2); and TrmD (0.1 g), RplS (0.1 g),
RnhB (0.2 g), Lp28.6 (0.1 g), and Lrr44.9 (0.1 g) (combo 3).
Statistical analysis. Data were analyzed using version 6.0 of the Sta-
tistica software package (StatSoft, Tulsa, OK). Cutoff values for each re-
combinant antigen ELISA were defined as the correspondingmean plus 2
standard deviations (SD) from the sera of healthy controls. Sensitivity was
defined as the percentage of the laboratory-confirmed cases of leptospi-
rosis whose serum samples gave mean ODs greater than the relevant cut-
off value. Specificity was calculated as the percentage of the control indi-
viduals whose samples gave mean ODs below the relevant cutoff value.
The positive and negative predictive values (PPV and NPV, respectively)
are the proportions of true positives and true negatives, respectively. The
percent agreement between the results of the recombinant protein-based
ELISA and the results of the MAT, and the corresponding kappa coeffi-
cients, were determined using Epi Info version 6.0 (Centers for Disease
Control and Prevention, Atlanta, GA). The LigA-C peptides identified in
our previous study (23)were used as positive controls in ELISA in order to
compare the diagnosis efficacy of the newly identified proteinswith that of
a well-defined in vivo-expressed protein.
Nucleotide sequence accession numbers. The sequences obtained
were submitted to GenBank with the accession numbers KF240786,
KF240787, KF240788, KF240789, KF270743, KF270744, KF270745,
KF270746, and KF270747 for recA, argC, lrr44.9, lp28.6, rnhB, rplS, trmD,
glpF, and fliD, respectively.
RESULTS
Prevalence of leptospirosis among samples. Among the 118
cases included in the study, circulating antileptospiral antibod-
ies were detected by MAT and titers were reported to be in the
range between 1:160 and 1:1,280. The most frequently ob-
served circulating serovar was Autumnalis (25.4%), followed
by Australis (17.8%) and Canicola (15.3%) (see Table S5 in the
supplemental material). Of the 118, 7 cases were found to be
culture positive, with 4 isolates identified as serovar Canicola
and 3 as Autumnalis.
Identification of immunoreactive proteins by DNA library
screening. Screening of approximately 105 plaques of the lambda
library revealed 18 reactive plaques, and final screening identified
highly expressive immunoreactive clones N2  4-3 III, N2 
16-1 III, andN2 17-3 III. Sequences of plasmids rescued from
the selected lambda phages were compared with genome se-
quences of L. interrogans serovar Lai strain 56601 and serovar
Copenhageni strain Fiocruz L1-130. Sequence analysis confirmed
two open reading frames in clone N2 4-3 III (argC and recA),
two in N2 16-1 III (glpF and fliD), and five in N2 17-3 III
(trmD, rplS, rnhB, lp28.6, and lrr44.9). The conservation of the
proteins among various leptospiral species was determined by
multiple-sequence alignment. The corresponding protein se-
quences (as given in Table 1) were retrieved from GenBank and
analyzed with the BioEdit sequence alignment editor (version
7.1.3.0). The proteins were found to be highly conserved (	80 to
100% sequence identity) among pathogenic leptospires but
shared	23 to 78% identity with their counterparts in nonpatho-
genic Leptospira biflexa and other pathogenic bacteria (Table 1; see
also Table S6 in the supplemental material).
Production of recombinant proteins and their immunoreac-
tivity. The purity of complete His6 tag fusion proteins ex-
pressed in either E. coli BL21(DE3) or E. coli BL21(DE3)pLysS
was confirmed by SDS-PAGE and Coomassie brilliant blue
staining (see Fig. S2 in the supplemental material). The deter-
mined molecular masses of the purified proteins were consis-
tent with those predicted from their amino acid compositions
(Table 1). The purified proteins were immunoblotted with
pooled patient sera, and the immunoreactivity of the purified
proteins was assessed (Fig. 1A).
In vivo expression of the identified proteins during natural
infection. Western blotting assays of the purified proteins devel-
oped with HIS (against laboratory culture N2) did not reveal re-
activity of the identified proteins except for RplS, RnhB, and
Lp28.6 (Fig. 1B). This made us hypothesize that the newly identi-
fied and characterized proteins ArgC, RecA, FliD, TrmD, and
Lrr44.9 could possibly be expressed during natural infection of the
host and not in vitro.
TABLE 1 Conservation of identified proteins among different species of Leptospira
Protein
GenBank
accession no.
Identity (%)a
Molecular
mass (kDa)L. interrogans L. borgpetersenii L. kirschneri L. weilii L. noguchii L. alexanderi L. santarosai L. kmetyi L. biflexa
ArgC AGW25359 98 84 97 83 92 83 84 84 59 37.8
RecA AGW25358 99 95 99 95 99 95 96 95 78 39
GlpF AGW25365 99 87 97 85 96 85 88 91 67 25.4
FliD AGW25366 99 87 98 94 96 89 87 92 53 69.9
TrmD AGW25364 99 91 98 91 96 90 NA 90 60 25.6
RplS AGW25363 99 90 96 92 96 87 88 93 68 15.5
RnhB AGW25362 99 81 92 83 92 82 92 81 41 26.5
Lp28.6 AGW25361 99 63 94 69 87 65 93 66 NA 28.6
Lrr44.9 AGW25360 100 93 98 93 98 93 94 91 44 44.96
a L. interrogans, YP_001698, WP_017861766, WP_000535417.1, NP_713634.1, NP_712569.1, NP_712568.1, NP_712567.2, WP_000778152.1, NP_712564.1; L. borgpetersenii,
WP_002761303, WP_002761315, WP_002752499.1, WP_002752524.1, WP_004280339.1, YP_798039.1, YP_798038.1, WP_002751302.1, WP_002751417.1; L. kirschneri,
WP_004779134, WP_004752583, WP_025183617.1, WP_004781580.1, WP_004760731.1, WP_004780226.1, WP_004780231.1, WP_020779461.1, WP_004751784.1; L. weilii,
WP_004504782, WP_002996988, WP_004506831.1, WP_003010986.1, WP_004507221.1, WP_002996170.1, WP_002995931.1, WP_002996364.1, WP_002996221.1; L. noguchii,
WP_004454314, WP_004424072, WP_004426432, WP_004426445.1, WP_004430719.1, WP_004453264.1, WP_004423647.1, WP_004430727.1, WP_004424196.1; L. alexanderi,
WP_010578142, WP_010578143, WP_020985028.1, WP_010576705.1, WP_010579003.1, WP_010579002.1, WP_010579001.1, WP_010579000.1, WP_010578998.1; L. santarosai,
WP_016754218, WP_004468644, WP_016755555.1, WP_004494481.1, WP_004487102.1, WP_020767000.1, WP_020766986.1, WP_004470165.1; L. kmetyi, WP_020985623,
WP_010574861, WP_010573697.1, WP_020985940.1, WP_010574774.1, WP_010574773.1, WP_010574772.1, WP_010574771.1, WP_010574769.1; L. biflexa, YP_001962522,
AAC43586, WP_012387177.1, YP_001837994.1, YP_001839046.1, YP_001839047.1, YP_001962701.1, YP_001839051.1. NA, not available.
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To further prove the proteins ArgC and RecA to be ex-
pressed in vivo, L. interrogans serovar Autumnalis strain N2-
MACS (mouse-adapted challenge strain) was selected from its
parent strain N2 (laboratory strain), by passaging the isolate in
BALB/cmice (cyclophosphamide treated) for	15 times. L. inter-
rogans strain N2-MACS was passaged in vitro (N2-MACS1, -2,
-3, and -4) four times. Heat-extracted antigens were prepared
from N2-MACS, N2-MACS1, N2-MACS2, N2-MACS3, N2-
MACS4, and N2 and immunoblotted with hyperimmune rab-
bit sera for ArgC/RecA/LipL32. The levels of ArgC and RecA
expression were significantly higher in N2-MACS and de-
creased as the isolates were passaged in vitro. No differential
expression was observed for LipL32 (Fig. 2).
Further to confirm that ArgC and RecA are not temperature
regulated, heat-extracted proteins of L. interrogans serovar Au-
tumnalis strain N2 grown at 30, 37, and 42°C were immuno-
blottedwithArgC/RecA-specific polyclonal rabbit serum.The im-
munoblots did not show any detectable level of ArgC/RecA (Fig. 3;
see also Fig. S3 in the supplemental material). In contrast, LipL32
was expressed by laboratory-grown cultures at different tempera-
tures. LigA-C was used as a positive control. This confirms that
ArgC and RecA are expressed in vivo and are not temperature
regulated.
Evaluation of the recombinant proteins in serological diag-
nosis. The optimum antigen concentration of the recombinant
protein to be utilized in IgM ELISA for serological diagnosis as
determined by checkerboard assay was 0.2 g/well. The mean
plus 2 SD of the absorbance values from healthy individuals
was defined as the cutoff value to achieve diagnostic specificity.
The cutoff values for the recombinant proteins were in the
range between 0.101 and 0.186 (Fig. 4A to I). ELISA with pu-
rified recombinant proteins demonstrated a sensitivity in the
range between 44.9 and 92.3% and a specificity between 46.9
and 96.9%. Among all the recombinant proteins analyzed,
ArgC had the highest sensitivity and specificity for the diagno-
sis of leptospirosis (Table 2). A positive correlation was dem-
onstrated between MAT titer and ELISA OD values (see Fig. S4
in the supplemental material). Then, we asked whether the
combination of recombinant proteins in ELISA format could
increase the sensitivity and specificity of the test. To test that,
we used three different combinations based on the immuno-
reactive clones obtained (N2   4-3 III, N2   16-1 III, and
N2   17-3 III): combo 1 (ArgC and RecA), combo 2 (GlpF
and FliD), and combo 3 (TrmD, RplS, RnhB, Lp28.6, and
Lrr44.9). The purified recombinant proteins were mixed per the
proportionsmentioned above andused in ELISA.As expected, the
combination of recombinant proteins increased the sensitivity.
FIG 1 Immunoreactivity of the purified proteins to patient sera or hyperim-
mune rabbit serum raised against laboratory-grown N2 strain. (A) Western
blot (WB) of the purified proteins probed with pooled patient sera. Purified
proteins: ArgC (37.8 kDa), RecA (39 kDa), GlpF (25.4 kDa), FliD (69.9 kDa),
TrmD (25.6 kDa), RplS (15.5 kDa), RnhB (26.5 kDa), Lp28.6 (28.6 kDa), and
Lrr44.9 (44.9 kDa). (B) Western blot of the purified proteins probed with
rabbit HIS. Purified proteins: ArgC (37.8 kDa), RecA (39 kDa), GlpF (25.4
kDa), FliD (69.9 kDa), TrmD (25.6 kDa), RplS (15.5 kDa), RnhB (26.5 kDa),
Lp28.6 (28.6 kDa), and Lrr44.9 (44.9 kDa).
FIG 2 ArgC and RecA are proteins expressed only during natural infection in vivo. Heat-extracted proteins from L. interrogans serovar Autumnalis strains
N2-MACS (lanes 1), N2-MACS1 (lanes 2), N2-MACS2 (lanes 3), N2-MACS3 (lanes 4), N2-MACS4 (lanes 5), and N2 (lanes 6) were immunoblotted with
hyperimmune rabbit sera for ArgC (A), RecA (B), and LipL32 (C). The levels of ArgC and RecA expression were significantly higher in N2-MACS and decreased
as the isolates were passaged in vitro. No differential expression was observed for LipL32.
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Combo 1 had a sensitivity of 95.7% and a specificity of 94.9%
(Table 2). The sensitivity of combo1ELISAwas	5 to 10%greater
than that of the ELISA using ArgC or RecA separately, and it was
comparable to the sensitivity and specificity (Table 2; see also Fig.
S5 in the supplemental material) of LigA-C peptides identified in
our previous study (23).
DISCUSSION
Leptospira interrogans has caused serious fatal illness worldwide.
The early clinical presentation of fever, headache, and myalgia
may be difficult to distinguish from febrile illness associated
with diseases such as dengue, viral hemorrhagic infections, and
rickettsiosis. Thus, an objective test that promptly detects the
causative Leptospira, its DNA, or a specific antibody would be
extremely valuable in guiding treatment and providing aware-
ness of outbreaks, thereby facilitating provisional diagnosis of
patients with clinical presentations/histories. In the present
study, the use of purified recombinant ArgC and RecA in com-
bination proved to be an effective antigen to provide conclusive
diagnosis of leptospirosis. Percent sensitivity and specificity
were
90% based on comparisons with sera of healthy individ-
uals and of patients with other febrile infectious diseases.
Humoral immune responses to pathogenic bacteria aremainly
directed at surface-exposed and secreted antigens accessible to
antibody in plasma and mucosal secretions. Thus, a screen of an
expression gene library with immune serum identifies a dispro-
portionately large number of proteins with sequences predictive
of surface exposure (25–27). A consequence of this approach has
been failure to consider cytoplasmic proteins. The proteins ArgC
and RecA used as effective antigens are cytoplasmic proteins of L.
interrogans that participate in host immune responses. Neither of
these proteins was identified in a recent high-density protein mi-
croarray of serovar Copenhageni for which the selection criteria
included potential biological importance and antigenic features
(13).
The majority of studies of putative virulence factors impor-
tant in microbial pathogenesis have focused on nonmetabolic
gene products. This is due, in part, to the belief that housekeep-
ing and other genes common to pathogens and nonpathogens
are unimportant for pathogenesis. In fact, during the crucial
early phase of microbial proliferation in vivo, the ability of the
pathogen to synthesize or acquire scarce/unavailable nutrients
becomes critical. For example, iron acquisition factors are well
accepted as important for leptospiral pathogenesis (17, 18).
Acquisition or synthesis of other nutritional factors is less well
appreciated but supported by a variety of reports (28–30). The
frequent identification of biosynthesis genes following library
screening of random gene fusions or randomly generated
transposon mutants argues for their importance in pathogen-
esis (28, 29, 31).
The findings to date suggest that decreased levels of arginine
in human urine induce argC. Disruption of the carAB gene
involved with arginine and pyrimidine biosynthesis signifi-
cantly reduced the ability of Salmonella to cause systemic infec-
tion (29). These studies also showed that in vivo arginine biosyn-
thesis is required for optimal renal infection but not for optimal
infection of bladder and urine. RecA is a ubiquitous bacterial re-
combination protein essential both for DNA transformation (32,
33) and for mediation of bacterial SOS responses (34). Coloniza-
tion and infection of host organs are potentially stressful for in-
vading pathogens because they include the effects of antibacterial
factors such as pH, elevated temperature, osmolarity, and factors
released by other microorganisms on the mucosal surface. Some
stresses result in DNA damage, the repair of which involves RecA,
an enzyme critical for pairing of single-strand DNA with comple-
mentary regions of double-stranded DNA. Single-strand DNA-
RecA produced following DNA injury activates self-catalysis of
LexA protein responsible for blocking expression of SOS genes for
proteins that repair DNA. Thus, RecA also functions as a LexA
coprotease. A significant decrease in intracellular pH has been
shown to result both in DNA damage via depurination in Salmo-
nella enterica serovar Typhimurium and in induction of the DNA
FIG 3 ArgC and RecA expression levels are not temperature regulated.Whole-cell lysate of L. interrogans serovar Autumnalis strain N2 grown at 30°C (lanes 1),
37°C (lanes 2), and 42°C (lanes 3) and purified recombinant protein (lanes 4), immunoblotted with hyperimmune rabbit sera for ArgC (A), RecA (B), LigA-C
(C), and LipL32 (D).
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repair protein PolA (35). RecA may enhance resistance to oxida-
tive killing by phagocytes based on evidence that a recA mutant
of Salmonella Typhimurium is sensitive to the killing effect of the
oxidative burst ofmacrophages (36). Furthermore, recAmutation
diminishes adherence to and colonization of rabbit intestine by
Vibrio cholerae (37). Infection by serovar Autumnalis and other
Leptospira serovars is clearly associated with consistent expression
of this immunogenic protein in the early stages of invasion/bacte-
remia, raising the possibility that it has a role in pathogenesis in
addition to that of DNA repair.
The identified in vivo-expressed proteins would have been in-
volved in infection and stress responses of L. interrogans and thus
are upregulated during infection and elicited specific IgM re-
sponses in patients during the acute phase. Further studies focus-
ing on the importance of the identified proteins will help deter-
mine whether these proteins represent site-specific ormore global
virulence factors.
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